In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Luminex, BD, and Prodesse all immediately complied with FDA's instructions in removing statements from their websites related to tests for the 2009 H1N1 flu virus.
Luminex will pay $4.35 million to settle a dispute filed by SUNY in December 2007, which alleged breach of contract.
For full-year 2008, Luminex reported a 39 percent increase in revenues, to $104.4 million from $75 million. The company anticipates 2009 revenues to grow between 25 percent and 34 percent.
An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.
An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.
In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.
Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.